DDX5010B-50 Mabthera (Rituximab) antibody

See related secondary antibodies

Search for all "Mabthera (Rituximab)"

Quick Overview

Mouse anti Human Mabthera (Rituximab) 109H9.06


More Views

  • DDX5010B-50
  • DDX5010B-50

Product Description for Mabthera (Rituximab)

Mouse anti Human Mabthera (Rituximab) 109H9.06.
Presentation: Biotin
Product is tested for ELISA (detection).

Properties for Mabthera (Rituximab)

Product Category Primary Antibodies
Quantity 50 µg
Presentation Biotin
Reactivity Hu
Applications E(detection)
Clonality Monoclonal
Clone 109H9.06
Host Mouse
Isotype IgG1
Shipping to Germany, USA/Canada
PDF datasheet View Datasheet
Manufacturer Dendritics SAS

Datasheet Extract

Mabthera® (Roche) (Rituximab)
Isotype control SM10B (for use in human samples)
Application DDX5010P-50 / DDX5010P-100 Purified: Bridging Elisa positive control for anti-Mabthera detection,
Capture antibody for anti-Mabthera detection.
DDX5010B-50 DDX5010B-100 Biotin: Detection antibody for Mabthera detection. 

DDX5011P-50 / DDX5011P-100 Purified: Bridging Elisa positive control for anti-Mabthera detection.
DDX5011B-50 DDX5011B-100 Biotin: Detection antibody for Mabthera detection. 

Usage recommendation:
*This monoclonal antibody may be used between 5-25μg/ml.
*Optimal dilution should be determined by each laboratory for each application.
*Coupled antibody: to maintain RT before use.
Background Mabthera ® (Rituximab) is a chimeric monoclonal antibody targeting the CD20 protein expressed on B cell surface. Mabthera ® (Rituximab ) destroys B cells and is therefore used to treat diseases such as lymphomas, leukemias, transplant rejection, and autoimmune disorders. Mabthera® (Rituximab) has also been shown to be an effect ive rheumatoid arthritis treatment, in cases where anti - TNF - alpha therapy is not satisfactory. We have generated a panel of anti - Mabthera® (anti - Rituximab) monoclonal murine antibodies. These antibodies can be used to develop and calibrate Mabthera (Rituximab) and anti - Mabthera (anti - Rituximab) detection assays.
Concentration 0.5 mg/ml
Storage -20°C. KEEP CONTENTS STERILE: no preservative.
Purified antibodies: avoid repeated freeze/thaw cycles.
Coupled antibodies: glycerol protects from freezing.
QMA Hyper D ion exchange chromatography
Buffer System:
Purified: 100 μg in 200 μl / 50 μg in 100 μl Tris-NaCl pH 8.
Coupled: 100 μg in 200 μl / 50 μg in 100 μl PBS 50% glycerol.
Mabthera ® (Rituximab), negative for remicade (infliximab) and roactemra (tocilizumab). 
Cross-reactivity: Negative for remicade (infliximab) and roactemra (tocilizumab).

Accessory Products

  • LinkedIn